Tratamiento del cáncer de laringe experiencia en el Instituto Oncológico ？Dr. Luis Razetti？

objective: the laryngeal cancer accounts for 20 % - 25.% of all the head and neck carcinomas. the current treatment includes various forms ranging from surgery for localized disease to concurrent schemes chemotherapy and radiotherapy for the advanced stages. method: the purpose of this study is to evaluate the results of the treatment of laryngeal carcinoma at our institution in the period 2000-2009. for what was done a retrospective study based on medical records of patients with histopathological diagnosis of laryngeal carcinoma, stage early and in advanced non-metastatic. the primary objective is to evaluate overall survival, according to the staging and or therapeutic modalities we used. the secondary endpoints included disease free survival, laringectomy free survival. results: for a total of 187 patients, the overall survival was significantly higher in early stages compared to advanced stages (p=0.023). the global survival in advanced stages did not differ statistically significant regardless of the type of treatment we applied. the free laringectomy survival and the disease free survival show a trend in favor of the preliminary final concurrent treatment in the advanced stages. the overall survival and disease free survival in early stages did not present variation according to the definitive treatment modality (p= 0.086). conclusions: radiotherapy offers comparable efficacy to surgery in early stages, multimodal treatment for advanced stages allows greater laringectomy free survival and disease free survival without apparent impact on overall free survival in relation to the radical surgery.